| Ημερομηνία | barcode | code | περιεχομενο | τιμή παραγωγός | χονδρική | λιανική |
|---|---|---|---|---|---|---|
| 05/2018 | 2803064901010 | 306490101 | MERIOFERT PS.INJ.SOL 75 IU 1 ΣΕΤ (1 VIAL + 1 PF.SYR x 1ML SOLV +2 ΒΕΛΟΝΕΣ) | 14.87 | 15.60 | 21.50 |
| 05/2018 | 2803064901065 | 306490106 | MERIOFERT PS.INJ.SOL 75 IU 10 ΣΕΤ (10 VIALS + 10 AMP x 1ML SOLV) | 166.30 | 174.45 | 210.80 |
| 05/2018 | 2803064902031 | 306490203 | MERIOFERT PS.INJ.SOL 150 IU 10 ΣΕΤ (10 VIALS + 10 PF.SYR x 1ML SOLV +2 ΒΕΛΟΝΕΣ) | 308.63 | 313.26 | 365.27 |
| 05/2018 | 2803064902062 | 306490206 | MERIOFERT PS.INJ.SOL 150 IU 10 ΣΕΤ (10 VIALS+ 10 AMP x 1ML SOLV) | 330.33 | 335.29 | 390.95 |
For the treatment of female infertility
Being a combination drug, Menotropins bind to the Follicle stimulating hormone receptor (which results in ovulation in the absence of sufficient endogenous Luteinizing hormone)and It also binds to the LH receptor, thereby stimulating proper hormone release. The drug contains both FSH and LH,therefore, it induces ovarian follicular growth and development as well as gonadal steroid production in women who do not have ovarian failure.FSH is the primary driver of follicular recruitment and growth in early folliculogenesis, while LH is important for ovarian steroidogenesis and is involved in the physiological events leading to development of a competent pre-ovulatory follicle